Dr. Reddy's Labs Q3 2025: Net Sales Down 14.6%, Profit Plummets 89.33%

• Dr. Reddy's Laboratories reported standalone net sales of Rs 4,282.70 crore in December 2025, a 14.6% decrease year-on-year.
• Quarterly net profit for December 2025 stood at Rs 90.60 crore, marking an 89.33% decline from Rs 849.40 crore in December 2024.
• EBITDA decreased by 67.79% to Rs 459.90 crore in December 2025 compared to Rs 1,427.80 crore in the previous year.
• Earnings Per Share (EPS) fell significantly to Rs 1.09 in December 2025 from Rs 10.20 in December 2024.
• Dr. Reddy's Labs shares closed at Rs 1,157.20 on January 20, 2026, showing negative returns of -8.11% over 6 months and -10.17% over 12 months.

Why It Matters: Dr. Reddy's Labs experienced a sharp decline in net sales and profit in Q3 2025, impacting share performance.